{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:37:28Z","timestamp":1783953448154,"version":"3.55.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004856","name":"New York State Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.hoc.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:26:54Z","timestamp":1716380814000},"page":"869-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Biomarkers in Cancer Screening"],"prefix":"10.1016","volume":"38","author":[{"given":"Indu","family":"Kohaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2024.04.004_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2024.04.004_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2024.04.004_bib3","article-title":"US Government releases National Cancer Plan","volume":"24","author":"Furlow","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib4","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2018, National Cancer Institute. Bethesda, MD, based on November 2020 SEER data submission, posted to the SEER web site, 2021. Available at: https:\/\/seer.cancer.gov\/csr\/1975_2018\/. Accessed April 2021."},{"key":"10.1016\/j.hoc.2024.04.004_bib5","article-title":"National Cancer Institute\u2019s early detection research network: a model organization for biomarker research","volume":"3","author":"SS","year":"2023","journal-title":"Journal of the National Cancer Center"},{"key":"10.1016\/j.hoc.2024.04.004_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jnci\/djaa004","article-title":"Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis","volume":"112","author":"Blackford","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.04.004_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib8","first-page":"292","article-title":"Results from 22 years of Followup in the G\u00f6teborg Randomized Population-Based Prostate Cancer Screening Trial","volume":"208","author":"Fr\u00e5nlund","year":"2022","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.hoc.2024.04.004_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of Prostatectomy versus Observation for Early Prostate Cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib10","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial","volume":"360","author":"Andriole","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.hoc.2024.04.004_bib12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bju.13505","article-title":"Correlation between stage shift and differences in mortality in the European Randomized study of Screening for Prostate Cancer (ERSPC)","volume":"118","author":"Bokhorst","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.hoc.2024.04.004_bib13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"USPST","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2024.04.004_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jamasurg.2021.1939","article-title":"Updated USPSTF Guidelines for Colorectal Cancer Screening: The Earlier the Better","volume":"156","author":"Stewart","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hoc.2024.04.004_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"USPST","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2024.04.004_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3322\/caac.20066","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.hoc.2024.04.004_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hoc.2024.04.004_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of Biomarker Development for Early Detection of Cancer","volume":"93","author":"Pepe","year":"2001","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.hoc.2024.04.004_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14694\/EdBook_AM.2015.35.57","article-title":"Early detection of cancer: past, present, and future","author":"Schiffman","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.hoc.2024.04.004_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiol.2017161519","article-title":"National performance benchmarks for modern diagnostic digital mammography: update from the Breast Cancer Surveillance Consortium","volume":"283","author":"Sprague","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.hoc.2024.04.004_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/M14-2086","article-title":"Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment","volume":"162","author":"Pinsky","year":"2015","journal-title":"Annals of internal medicine"},{"key":"10.1016\/j.hoc.2024.04.004_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1370\/afm.942","article-title":"Cumulative incidence of false-positive results in repeated, multimodal cancer screening","volume":"7","author":"Croswell","year":"2009","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10549-017-4286-5","article-title":"Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results","volume":"164","author":"Narayan","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.hoc.2024.04.004_bib26","article-title":"Predictors of cervical cancer screening adherence in the United States: a systematic review","volume":"5","author":"Limmer","year":"2014","journal-title":"Journal of the advanced practitioner in oncology"},{"key":"10.1016\/j.hoc.2024.04.004_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106022","article-title":"Predictors of overall and test-specific colorectal cancer screening adherence","volume":"133","author":"Daskalakis","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amepre.2019.03.015","article-title":"Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis","volume":"57","author":"Zahnd","year":"2019","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1258\/jms.2012.012010","article-title":"Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?","volume":"19","author":"Pinsky","year":"2012","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.hoc.2024.04.004_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1472-6963-6-122","article-title":"Disparities in preventive procedures: comparisons of self-report and Medicare claims data","volume":"6","author":"Fiscella","year":"2006","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1074\/mcp.M112.021618","article-title":"Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes","volume":"12","author":"Villarreal","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.hoc.2024.04.004_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1940-6207.CAPR-22-0435","article-title":"PreCancer Atlas: Present and Future","volume":"16","author":"Srivastava","year":"2023","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2013risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0036-1584091","article-title":"Colonic Polyps: Diagnosis and Surveillance","volume":"29","author":"Huck","year":"2016","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.hoc.2024.04.004_bib35","doi-asserted-by":"crossref","first-page":"474905","DOI":"10.1155\/2014\/474905","article-title":"Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN","volume":"2014","author":"Distler","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.hoc.2024.04.004_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/ijd.16164","article-title":"The risk of metastases from squamous cell carcinoma of the skin","volume":"62","author":"Caudill","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.hoc.2024.04.004_bib37","first-page":"609","article-title":"Behavior of moderate cervical dysplasia during long-term follow-up","volume":"61","author":"Nasiell","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.hoc.2024.04.004_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/1940-6207.CAPR-15-0305","article-title":"Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma","author":"Merrick","year":"2016","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cgh.2012.09.010","article-title":"Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs","volume":"11","author":"Corley","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hoc.2024.04.004_bib41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.pan.2018.07.009","article-title":"Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model","volume":"18","author":"Peters","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.hoc.2024.04.004_bib42","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s13555-020-00425-4","article-title":"Management Pearls on the Treatment of Actinic Keratoses and Field Cancerization","volume":"10","author":"Piquero-Casals","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.hoc.2024.04.004_bib43","first-page":"327","article-title":"High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer","volume":"2","author":"Zynger","year":"2009","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.hoc.2024.04.004_bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thoraxjnl-2018-212263","article-title":"Probability of cancer in lung nodules using sequential volumetric screening up to 12\u00a0months: the UKLS trial","volume":"74","author":"Marcus","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.hoc.2024.04.004_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jcmgh.2021.07.014","article-title":"Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer","volume":"13","author":"Grimont","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.hoc.2024.04.004_bib46","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s41467-022-29212-9","article-title":"Comprehensive generation, visualization, and reporting of quality control metrics for single-cell RNA sequencing data","volume":"13","author":"Hong","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2024.04.004_bib47","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","article-title":"Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in\u00a0situ: Analysis of TBCRC 038 and RAHBT cohorts","volume":"40","author":"Strand","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hoc.2024.04.004_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2144\/05384SU04","article-title":"Biomarkers in molecular medicine: cancer detection and diagnosis","volume":"Suppl","author":"Maruvada","year":"2005","journal-title":"Biotechniques"},{"key":"10.1016\/j.hoc.2024.04.004_bib50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2017.01.031","article-title":"Translating Germline Cancer Risk into Precision Prevention","volume":"168","author":"Yurgelun","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.hoc.2024.04.004_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines(R) Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024","volume":"21","author":"Daly","year":"2023","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.hoc.2024.04.004_bib52","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.hoc.2024.04.004_bib53","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch Syndrome Genetics and Clinical Implications","volume":"164","author":"Peltomaki","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hoc.2024.04.004_bib54","unstructured":"FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types. 2023, FDA News Release."},{"key":"10.1016\/j.hoc.2024.04.004_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1021\/acschembio.7b00715","article-title":"Development of a Protease Biosensor Based on a Dimerization-Dependent Red Fluorescent Protein","volume":"13","author":"Mitchell","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.hoc.2024.04.004_bib56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.snb.2006.04.096","article-title":"Development of a protease biosensor utilizing silica nanobeads","volume":"121","author":"Grant","year":"2007","journal-title":"Sensor Actuator B Chem"},{"key":"10.1016\/j.hoc.2024.04.004_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41551-019-0358-7","article-title":"Non-invasive early detection of acute transplant rejection via nanosensors of granzyme B activity","volume":"3","author":"Mac","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.hoc.2024.04.004_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw0262","article-title":"Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling","volume":"12","author":"Kirkpatrick","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib59","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41565-023-01372-9","article-title":"CRISPR-Cas-amplified urinary biomarkers for multiplexed and portable cancer diagnostics","volume":"18","author":"Hao","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.hoc.2024.04.004_bib60","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1039\/C6MB00231E","article-title":"Small-molecule binding sites to explore protein-protein interactions in the cancer proteome","volume":"12","author":"Xu","year":"2016","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.hoc.2024.04.004_bib61","first-page":"1","article-title":"Application of Fluorescent Probes in Reactive Oxygen Species Disease Model","author":"Niu","year":"2022","journal-title":"Crit Rev Anal Chem"},{"key":"10.1016\/j.hoc.2024.04.004_bib62","doi-asserted-by":"crossref","first-page":"17563","DOI":"10.1002\/anie.201906261","article-title":"Volatile Organic Compound Based Probe for Induced Volatolomics of Cancers","volume":"58","author":"Lange","year":"2019","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.hoc.2024.04.004_bib63","doi-asserted-by":"crossref","first-page":"58238","DOI":"10.1021\/acsami.1c19824","article-title":"Dynamic Protein Corona of Gold Nanoparticles with an Evolving Morphology","volume":"13","author":"Nandakumar","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.hoc.2024.04.004_bib64","doi-asserted-by":"crossref","DOI":"10.1116\/6.0000540","article-title":"Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles","volume":"16","author":"Digiacomo","year":"2021","journal-title":"Biointerphases"},{"key":"10.1016\/j.hoc.2024.04.004_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114575","article-title":"Bovine serum albumin-gold nanoclusters protein corona stabilized polystyrene nanoparticles as dual-color fluorescent nanoprobes for breast cancer detection","volume":"215","author":"Wu","year":"2022","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.hoc.2024.04.004_bib66","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1021\/nn303130d","article-title":"Determination of the Quantum Dot Band Gap Dependence on Particle Size from Optical Absorbance and Transmission Electron Microscopy Measurements","volume":"6","author":"Segets","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.hoc.2024.04.004_bib67","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/ar3000585","article-title":"Quantum dot cytotoxicity and ways to reduce it","volume":"46","author":"Winnik","year":"2013","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib68","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2147\/IJN.S157135","article-title":"Dysfunction of various organelles provokes multiple cell death after quantum dot exposure","volume":"13","author":"Wang","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.hoc.2024.04.004_bib69","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1166\/jnn.2019.15807","article-title":"Systematic Toxicity Evaluations of High-Performance Carbon \u201cQuantum\u201d Dots","volume":"19","author":"Liu","year":"2019","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.hoc.2024.04.004_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12951-020-00698-z","article-title":"Synthesis of graphene quantum dots and their applications in drug delivery","volume":"18","author":"Zhao","year":"2020","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.hoc.2024.04.004_bib71","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/metabo12030268","article-title":"Citric Acid as a Potential Prostate Cancer Biomarker Determined in Various Biological Samples","volume":"12","author":"Buszewska-Forajta","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.hoc.2024.04.004_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.120622","article-title":"Prostate cancer biomarker citrate detection using triaminoguanidinium carbon dots, its applications in live cells and human urine samples","volume":"268","author":"Rajalakshmi","year":"2022","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"10.1016\/j.hoc.2024.04.004_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41467-017-00153-y","article-title":"In\u00a0vivo cation exchange in quantum dots for tumor-specific imaging","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.hoc.2024.04.004_bib74","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jgm.2992","article-title":"Non-invasive detection of bladder cancer via expression-targeted gene delivery","volume":"19","author":"Fang","year":"2017","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ebiom.2016.03.043","article-title":"Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer","volume":"7","author":"Kelly","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.hoc.2024.04.004_bib76","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41587-019-0064-8","article-title":"Engineered immune cells as highly sensitive cancer diagnostics","volume":"37","author":"Aalipour","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.hoc.2024.04.004_bib77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1039\/c5ib00047e","article-title":"Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker","volume":"7","author":"Panteli","year":"2015","journal-title":"Integr Biol"},{"key":"10.1016\/j.hoc.2024.04.004_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3519","article-title":"Programmable probiotics for detection of cancer in urine","volume":"7","author":"Danino","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib79","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.adf3974","article-title":"Engineered bacteria detect tumor DNA","volume":"381","author":"Cooper","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.hoc.2024.04.004_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.37349\/etat.2023.00125","article-title":"Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer","volume":"4","author":"Caputo","year":"2023","journal-title":"Explor Target Antitumor Ther"},{"key":"10.1016\/j.hoc.2024.04.004_bib82","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/bios12110956","article-title":"Novel Pumping Methods for Microfluidic Devices: A Comprehensive Review","volume":"12","author":"Iakovlev","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.hoc.2024.04.004_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/mi12080885","article-title":"SMILE Platform: An Innovative Microfluidic Approach for On-Chip Sample Manipulation and Analysis in Oral Cancer Diagnosis","volume":"12","author":"Zoupanou","year":"2021","journal-title":"Micromachines"},{"key":"10.1016\/j.hoc.2024.04.004_bib84","doi-asserted-by":"crossref","first-page":"100339","DOI":"10.18632\/oncotarget.22225","article-title":"Endothelial-derived interleukin-6 induces cancer stem cell motility by generating a chemotactic gradient towards blood vessels","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hoc.2024.04.004_bib85","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1039\/b504737d","article-title":"Detection of picomolar levels of interleukin-8 in human saliva by SPR","volume":"5","author":"Yang","year":"2005","journal-title":"Lab Chip"},{"key":"10.1016\/j.hoc.2024.04.004_bib86","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/jacs.6b12236","article-title":"Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip","volume":"139","author":"Park","year":"2017","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.hoc.2024.04.004_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-019-0107-0","article-title":"Precision cell-free DNA extraction for liquid biopsy by integrated microfluidics","volume":"4","author":"Lee","year":"2020","journal-title":"npj Precis Onc"},{"key":"10.1016\/j.hoc.2024.04.004_bib88","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1021\/acsbiomaterials.1c00831","article-title":"Beyond PDMS and Membranes: New Materials for Organ-on-a-Chip Devices","volume":"7","author":"Radisic","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.hoc.2024.04.004_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.609355","article-title":"3D-Printed Microfluidics and Potential Biomedical Applications","volume":"3","author":"Prabhakar","year":"2021","journal-title":"Frontiers in Nanotechnology"},{"key":"10.1016\/j.hoc.2024.04.004_bib90","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.3390\/s23208524","article-title":"Extending the Shelf-Life of Immunoassay-Based Microfluidic Chips through Freeze-Drying Sublimation Techniques","volume":"23","author":"Moon","year":"2023","journal-title":"Sensors"},{"key":"10.1016\/j.hoc.2024.04.004_bib91","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1373\/clinchem.2007.095992","article-title":"DNA methylation biomarkers for blood-based colorectal cancer screening","volume":"54","author":"Lofton-Day","year":"2008","journal-title":"Clin Chem."},{"key":"10.1016\/j.hoc.2024.04.004_bib92","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1373\/clinchem.2013.221044","article-title":"Validation of a Real-Time PCR\u2013Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma","volume":"60","author":"Potter","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.hoc.2024.04.004_bib93","unstructured":"Bluestar genomics presents positive results from validation study in pancreatic cancer detection at American pancreatic association (APA), Bluestar Genomics, Inc. News Release."},{"key":"10.1016\/j.hoc.2024.04.004_bib94","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1200\/JCO.22.01979","article-title":"Performance and Operational Feasibility of Epstein-Barr Virus-Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches","volume":"41","author":"Lou","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib95","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.hoc.2024.04.004_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s43856-022-00088-6","article-title":"Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test","volume":"2","author":"Hinestrosa","year":"2022","journal-title":"Commun Med"},{"key":"10.1016\/j.hoc.2024.04.004_bib97","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2024.04.004_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102041","article-title":"A\u00a0panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study","volume":"61","author":"Luan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.hoc.2024.04.004_bib99","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb9601","article-title":"Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention","volume":"369","author":"Lennon","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.hoc.2024.04.004_bib101","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41416-020-01223-7","article-title":"Transforming the landscape of early cancer detection using blood tests-Commentary on current methodologies and future prospects","volume":"124","author":"Liu","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hoc.2024.04.004_bib102","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.3390\/cancers13143501","article-title":"The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice","volume":"13","author":"Nadauld","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.hoc.2024.04.004_bib103","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/gkw116","article-title":"Distribution of miRNA expression across human tissues","volume":"44","author":"Ludwig","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.hoc.2024.04.004_bib104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating cell-free microRNAs in cancer","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib105","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/cancers14061450","article-title":"A\u00a0Novel Blood-Based microRNA Diagnostic Model with High Accuracy for Multi-Cancer Early Detection","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.hoc.2024.04.004_bib106","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac080","article-title":"Prediction of tissue-of-origin of early stage cancers using serum miRNomes","volume":"7","author":"Matsuzaki","year":"2023","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.hoc.2024.04.004_bib108","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jnci\/djab168","article-title":"Multicancer Early Detection: Learning From the Past to Meet the Future","volume":"114","author":"Etzioni","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.04.004_bib109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2024.04.004_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jnci\/djac218","article-title":"Study design considerations for trials to evaluate multicancer early detection assays for clinical utility","volume":"115","author":"Minasian","year":"2022","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2024.04.004_bib111","article-title":"Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies","author":"Etzioni","year":"2023","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.hoc.2024.04.004_bib112","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1158\/1055-9965.EPI-20-0237","article-title":"The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers","volume":"29","author":"Srivastava","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.hoc.2024.04.004_bib113","series-title":"The early detection research network. Fifth report","year":"2011"},{"key":"10.1016\/j.hoc.2024.04.004_bib114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPA.0000000000001762","article-title":"Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review","volume":"50","author":"Kenner","year":"2021","journal-title":"Pancreas"},{"key":"10.1016\/j.hoc.2024.04.004_bib115","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2020.09.006","article-title":"Cancer Biomarkers and Big Data: A Planetary Science Approach","volume":"38","author":"Crichton","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:47:14Z","timestamp":1719877634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0889858824000467"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.04.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Cancer Screening","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}